187. J Nanobiotechnology. 2018 Mar 22;16(1):26. doi: 10.1186/s12951-018-0359-9.Functionalized rare earth-doped nanoparticles for breast cancer nanodiagnosticusing fluorescence and CT imaging.Jain A(1)(2)(3), Fournier PGJ(1), Mendoza-Lavaniegos V(4)(5), Sengar P(1)(2)(3), Guerra-Olvera FM(1), Iñiguez E(4)(5), Kretzschmar TG(4)(5), Hirata GA(3), Juárez P(6).Author information: (1)Biomedical Innovation Department, Centro de Investigación Científica y deEducación Superior de Ensenada (CICESE), Carretera Ensenada-Tijuana No. 3918,Zona Playitas, C.P. 22860, Ensenada, B.C., Mexico.(2)Posgrado en Física de Materiales, Centro de Investigación Científica y deEducación Superior de Ensenada (CICESE), Carretera Ensenada-Tijuana No. 3918,Zona Playitas, C.P. 22860, Ensenada, B.C., Mexico.(3)Universidad Nacional Autónoma de México (UNAM)-Centro de Nanociencias yNanotecnología (CNyN), Km. 107 Carretera Tijuana-Ensenada, C.P. 22860, Ensenada, B.C., Mexico.(4)Departamento de Geología, Centro de Investigación Científica y de EducaciónSuperior de Ensenada (CICESE), Carretera Transpeninsular Ensenada-Tijuana #318,Zona Playitas, C.P. 22860, Ensenada, B.C., Mexico.(5)Centro Mexicano de Innovación en Energía Geotérmica (CeMIGeo), Rinconada delPedregal 95, Pedregal Playitas, 22860, Ensenada, Baja California, Mexico.(6)Biomedical Innovation Department, Centro de Investigación Científica y deEducación Superior de Ensenada (CICESE), Carretera Ensenada-Tijuana No. 3918,Zona Playitas, C.P. 22860, Ensenada, B.C., Mexico. pjuarez@cicese.mx.BACKGROUND: Breast cancer is the second leading cause of cancer death among womenand represents 14% of death in women around the world. The standard diagnosismethod for breast tumor is mammography, which is often related withfalse-negative results leading to therapeutic delays and contributing indirectly to the development of metastasis. Therefore, the development of new tools thatcan detect breast cancer is an urgent need to reduce mortality in women. Here, wehave developed Gd2O3:Eu3+ nanoparticles functionalized with folic acid (FA), for breast cancer detection.RESULTS: Gd2O3:Eu3+ nanoparticles were synthesized by sucrose assisted combustionsynthesis and functionalized with FA using EDC-NHS coupling. The FA-conjugatedGd2O3:Eu3+ nanoparticles exhibit strong red emission at 613 nm with a quantumyield of ~ 35%. In vitro cytotoxicity studies demonstrated that the nanoparticleshad a negligible cytotoxic effect on normal 293T and T-47D breast cancer cells.Cellular uptake analysis showed significantly higher internalization ofFA-conjugated RE nanoparticles into T-47D cells (Folr hi ) compared to MDA-MB-231breast cancer cells (Folr lo ). In vivo confocal and CT imaging studies indicatedthat FA-conjugated Gd2O3:Eu3+ nanoparticles accumulated more efficiently in T-47Dtumor xenograft compared to the MDA-MB-231 tumor. Moreover, we found thatFA-conjugated Gd2O3:Eu3+ nanoparticles were well tolerated at high doses(300 mg/kg) in CD1 mice after an intravenous injection. Thus, FA-conjugatedGd2O3:Eu3+ nanoparticles have great potential to detect breast cancer.CONCLUSIONS: Our findings provide significant evidence that could permit thefuture clinical application of FA-conjugated Gd2O3:Eu3+ nanoparticles alone or incombination with the current detection methods to increase its sensitivity andprecision.DOI: 10.1186/s12951-018-0359-9 PMCID: PMC5863469PMID: 29566719 